PT87332A - Method of purification of product of expression of recombinant ferment - Google Patents

Method of purification of product of expression of recombinant ferment

Info

Publication number
PT87332A
PT87332A PT198887332A PT8733288A PT87332A PT 87332 A PT87332 A PT 87332A PT 198887332 A PT198887332 A PT 198887332A PT 8733288 A PT8733288 A PT 8733288A PT 87332 A PT87332 A PT 87332A
Authority
PT
Portugal
Prior art keywords
ferment
recombinant
purification
expression
product
Prior art date
Application number
PT198887332A
Other languages
English (en)
Other versions
PT87332B (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PT87332A publication Critical patent/PT87332A/pt
Publication of PT87332B publication Critical patent/PT87332B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT87332A 1987-03-30 1988-04-26 Metodo de purificacao de produto de expressao de levedura recombinante PT87332B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3232687A 1987-03-30 1987-03-30

Publications (2)

Publication Number Publication Date
PT87332A true PT87332A (pt) 1988-05-01
PT87332B PT87332B (pt) 1992-07-31

Family

ID=21864341

Family Applications (2)

Application Number Title Priority Date Filing Date
PT87137A PT87137B (pt) 1987-03-30 1988-03-30 Processo de preparacao do produto de expressao de levedura recombinante
PT87332A PT87332B (pt) 1987-03-30 1988-04-26 Metodo de purificacao de produto de expressao de levedura recombinante

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT87137A PT87137B (pt) 1987-03-30 1988-03-30 Processo de preparacao do produto de expressao de levedura recombinante

Country Status (9)

Country Link
EP (1) EP0309555A4 (pt)
JP (1) JPH01503514A (pt)
AU (1) AU617668B2 (pt)
ES (1) ES2009587A6 (pt)
IL (1) IL85905A0 (pt)
NZ (1) NZ224086A (pt)
PT (2) PT87137B (pt)
WO (1) WO1988007546A1 (pt)
ZA (1) ZA882272B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA856655B (en) * 1984-09-12 1986-04-30 Univ New York Cross-reactive and protective epitopes of circumsporozoite proteins
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
EP0229829B1 (en) * 1985-07-12 1995-02-22 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine

Also Published As

Publication number Publication date
PT87137A (pt) 1988-04-01
WO1988007546A1 (en) 1988-10-06
NZ224086A (en) 1991-02-26
JPH01503514A (ja) 1989-11-30
EP0309555A1 (en) 1989-04-05
AU1593688A (en) 1988-11-02
ZA882272B (en) 1988-09-22
PT87137B (pt) 1992-07-31
IL85905A0 (en) 1988-09-30
AU617668B2 (en) 1991-12-05
PT87332B (pt) 1992-07-31
ES2009587A6 (es) 1989-10-01
EP0309555A4 (en) 1990-04-10

Similar Documents

Publication Publication Date Title
NO175716C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, totale og partielle hyaluronsyre-estere
DE68911239D1 (de) Reinigungsverfahren von rohem Glycerol.
HUT39462A (en) Process for the purification of proteins
ES546654A0 (es) Metodo de produccion de factor viii:c humano
GB8508340D0 (en) Production of protein
DE69312205D1 (de) Reinigungsmethode von Rohprodukt
DK179785A (da) Fermenteringsproces
KR890701577A (ko) 시토칼라신 정제법 및 조성물
PT87332A (pt) Method of purification of product of expression of recombinant ferment
DE3569750D1 (en) Method of continuously recovering fermentation products
IL80448A0 (en) Purification of proteins
HU900124D0 (en) Process and solventmixture for purification of amfotericyn b
FI885914A (fi) Kokolihasta muotoiltujen tuotteiden valmistusmenetelmä
KR880005263A (ko) 단백질의 신규제법
EP0308336A3 (en) Process for the production of human pro-apolipoprotein a-i-like proteins
IT8647839A0 (it) Metodo di produzione di ferroleghe
GB8600199D0 (en) Production of protein
PT86636A (pt) Process for the preparation of azetidine and of novel intermediates therefor
GB8526951D0 (en) Production of protein
IL86699A0 (en) Cell system for expression of recombinant protein without production of virus
IT1202498B (it) Coltura di antera di pomodoro
IT1203510B (it) Procedimento per la produzione contunua di isoftalodinitrile
RO92640A2 (ro) Metoda pentru tratamentul keratitelor virotice
GB8728975D0 (en) Purification of recombinant protein
ZA863081B (en) Production of protein

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920110